Klebsiella pneumoniae is community-acquired infection it can present as lung tuberculosis. It is difficult to treat K. pneumoniae because of its enlarged capsule. "The most effective treatments for Klebsiella are 3&4 century carbapenems, quinolones, or cephalosporins." With the use of more recent medications, single therapy is similarly beneficial as combination therapy for lung infection. Successful treatment in the past has involved the use of older medicines that had less Klebsiella involvement. Prior to identification of pneumococcus illness, patient effect to tuberculosis, and ceftriaxone monotherapy was the prescribed treatment. The patient received an injection at first, followed by three weeks of oral medication. The patient received an injection at first, followed by 3 weeks of oral medication. This article's goal is to discuss the epidemiology, virulence factors, and treatment approaches of this particular species of bacterium. The bacteriais widely distributed throughout the nation, causing a number of respiratory illnesses and having the ability to transmit to other pathogens, including viruses, especially the Corona virus.